Philips to acquire The Spectranetics Corporation

13:15 EDT 30 Jun 2017 | CentreWatch

Royal Philips, a global leader in health technology, and The Spectranetics Corporation, a U.S.-based global provider of vascular intervention and lead management solutions, have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Spectranetics for $38.50 per share, to […]

The post Philips to acquire The Spectranetics Corporation appeared first on CenterWatch News Online.

Original Article: Philips to acquire The Spectranetics Corporation


More From BioPortfolio on "Philips to acquire The Spectranetics Corporation"

Quick Search


Relevant Topics

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...